Daily Archives: June 29, 2016
Gemcitabine Activates Natural Killer Cells to Attenuate Pancreatic Cancer Recurrence
With an overall 5-year survival rate of only 7%, pancreatic ductal adenocarcinoma (PDA) has now eclipsed breast cancer as the third leading cause of cancer death in the United States1 and it is predicted to be second by 2030.2 Despite improvements in s… Continue reading
Posted in News
Comments Off on Gemcitabine Activates Natural Killer Cells to Attenuate Pancreatic Cancer Recurrence
Gemcitabine Activates Natural Killer Cells to Attenuate Pancreatic Cancer Recurrence
With an overall 5-year survival rate of only 7%, pancreatic ductal adenocarcinoma (PDA) has now eclipsed breast cancer as the third leading cause of cancer death in the United States1 and it is predicted to be second by 2030.2 Despite improvements in s… Continue reading
Posted in News
Comments Off on Gemcitabine Activates Natural Killer Cells to Attenuate Pancreatic Cancer Recurrence
Exam 3: Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease
Posted in News
Comments Off on Exam 3: Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease
Exam 3: Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease
Posted in News
Comments Off on Exam 3: Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease
PPIs and Chronic Kidney Disease: Another Association to Worry About?
Lazarus B, Chen Y, Wilson FP, et al. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med 2016;176:238–246. Continue reading
Posted in News
Comments Off on PPIs and Chronic Kidney Disease: Another Association to Worry About?
PPIs and Chronic Kidney Disease: Another Association to Worry About?
Lazarus B, Chen Y, Wilson FP, et al. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med 2016;176:238–246. Continue reading
Posted in News
Comments Off on PPIs and Chronic Kidney Disease: Another Association to Worry About?
Exam 2: Unraveling a Patient’s Postoperative Symptoms
Posted in News
Comments Off on Exam 2: Unraveling a Patient’s Postoperative Symptoms
Concurrent Lower Gastrointestinal Bleeding Risk and Myocardial Ischemic Risk: Resume Aspirin or Not?
Teleologically, when there is bleeding, the natural response of the body is to promote clotting. This makes perfect sense if there is external injury that leads to bleeding and the response is also useful for some forms of internal “injury,” such a… Continue reading
Posted in News
Comments Off on Concurrent Lower Gastrointestinal Bleeding Risk and Myocardial Ischemic Risk: Resume Aspirin or Not?
Concurrent Lower Gastrointestinal Bleeding Risk and Myocardial Ischemic Risk: Resume Aspirin or Not?
Teleologically, when there is bleeding, the natural response of the body is to promote clotting. This makes perfect sense if there is external injury that leads to bleeding and the response is also useful for some forms of internal “injury,” such a… Continue reading
Posted in News
Comments Off on Concurrent Lower Gastrointestinal Bleeding Risk and Myocardial Ischemic Risk: Resume Aspirin or Not?
Two-Step Forward Genetic Screen in Mice Identifies the Ral Pathway as a Central Drug Target in Hepatocellular Carcinoma
A detailed understanding of the genetic background of hepatocellular carcinoma (HCC) will be crucial to developing new therapies aimed at selected targets.1 Given the sparse treatment options of advanced HCC, such progress is needed urgently for this h… Continue reading
Posted in News
Comments Off on Two-Step Forward Genetic Screen in Mice Identifies the Ral Pathway as a Central Drug Target in Hepatocellular Carcinoma